ARQT
Arcutis Biotherapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$23.90
+1.01%Margins
Gross margin
91.1%
EBITDA margin
9.5%
EBIT margin
7.4%
Net margin
6.1%
FCF margin
8.4%
12.9%
Return on equity
5.8%
Return on assets
10.2%
Return on invested capital
0.98x
Asset turnover
$39.3M
Cash from operations
$1.90
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026